Cargando…
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the ongoing global pandemic that poses substantial challenges to public health worldwide. A subset of COVID-19 patients experience systemic inflammatory response, known as cytokine storm,...
Autores principales: | Xu, Gang, Li, Ying, Zhang, Shengyuan, Peng, Haoran, Wang, Yunyun, Li, Dekang, Jin, Taijie, He, Zhuohao, Tong, Yilun, Qi, Chunting, Wu, Guowei, Dong, Kangyun, Gou, Jizhou, Liu, Yang, Xiao, Tongyang, Qu, Jing, Li, Liang, Liu, Liang, Zhao, Ping, Zhang, Zheng, Yuan, Junying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522117/ https://www.ncbi.nlm.nih.gov/pubmed/34663909 http://dx.doi.org/10.1038/s41422-021-00578-7 |
Ejemplares similares
-
Discovery of a cooperative mode of inhibiting RIPK1 kinase
por: Meng, Huyan, et al.
Publicado: (2021) -
PP6 negatively modulates LUBAC-mediated M1-ubiquitination of RIPK1 and c-FLIP(L) to promote TNFα-mediated cell death
por: Wu, Guowei, et al.
Publicado: (2022) -
SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination
por: Wei, Ran, et al.
Publicado: (2017) -
RIPK1-Associated Inborn Errors of Innate Immunity
por: Zhang, Jiahui, et al.
Publicado: (2021) -
HOIP modulates the stability of GPx4 by linear ubiquitination
por: Dong, Kangyun, et al.
Publicado: (2022)